Predrag Klasnja1, Eric B Hekler2, Saul Shiffman3, Audrey Boruvka4, Daniel Almirall5, Ambuj Tewari4, Susan A Murphy4. 1. School of Information, University of Michigan. 2. School of Nutrition and Health Promotion, Arizona State University. 3. Department of Psychology, University of Pittsburgh. 4. Department of Statistics, University of Michigan. 5. Institute of Social Research, University of Michigan.
Abstract
OBJECTIVE: This article presents an experimental design, the microrandomized trial, developed to support optimization of just-in-time adaptive interventions (JITAIs). JITAIs are mHealth technologies that aim to deliver the right intervention components at the right times and locations to optimally support individuals' health behaviors. Microrandomized trials offer a way to optimize such interventions by enabling modeling of causal effects and time-varying effect moderation for individual intervention components within a JITAI. METHOD: The article describes the microrandomized trial design, enumerates research questions that this experimental design can help answer, and provides an overview of the data analyses that can be used to assess the causal effects of studied intervention components and investigate time-varying moderation of those effects. RESULTS: Microrandomized trials enable causal modeling of proximal effects of the randomized intervention components and assessment of time-varying moderation of those effects. CONCLUSION: Microrandomized trials can help researchers understand whether their interventions are having intended effects, when and for whom they are effective, and what factors moderate the interventions' effects, enabling creation of more effective JITAIs. (PsycINFO Database Record (c) 2015 APA, all rights reserved).
OBJECTIVE: This article presents an experimental design, the microrandomized trial, developed to support optimization of just-in-time adaptive interventions (JITAIs). JITAIs are mHealth technologies that aim to deliver the right intervention components at the right times and locations to optimally support individuals' health behaviors. Microrandomized trials offer a way to optimize such interventions by enabling modeling of causal effects and time-varying effect moderation for individual intervention components within a JITAI. METHOD: The article describes the microrandomized trial design, enumerates research questions that this experimental design can help answer, and provides an overview of the data analyses that can be used to assess the causal effects of studied intervention components and investigate time-varying moderation of those effects. RESULTS: Microrandomized trials enable causal modeling of proximal effects of the randomized intervention components and assessment of time-varying moderation of those effects. CONCLUSION: Microrandomized trials can help researchers understand whether their interventions are having intended effects, when and for whom they are effective, and what factors moderate the interventions' effects, enabling creation of more effective JITAIs. (PsycINFO Database Record (c) 2015 APA, all rights reserved).
Authors: William T Riley; Daniel E Rivera; Audie A Atienza; Wendy Nilsen; Susannah M Allison; Robin Mermelstein Journal: Transl Behav Med Date: 2011-03 Impact factor: 3.046
Authors: Santosh Kumar; Wendy J Nilsen; Amy Abernethy; Audie Atienza; Kevin Patrick; Misha Pavel; William T Riley; Albert Shar; Bonnie Spring; Donna Spruijt-Metz; Donald Hedeker; Vasant Honavar; Richard Kravitz; R Craig Lefebvre; David C Mohr; Susan A Murphy; Charlene Quinn; Vladimir Shusterman; Dallas Swendeman Journal: Am J Prev Med Date: 2013-08 Impact factor: 5.043
Authors: Eric B Hekler; Matthew P Buman; Jennifer Otten; Cynthia M Castro; Lauren Grieco; Bess Marcus; Robert H Friedman; Melissa A Napolitano; Abby C King Journal: Int J Behav Nutr Phys Act Date: 2013-09-22 Impact factor: 6.457
Authors: Anne M Nielsen; Whitney A Welch; Kara L Gavin; Alison M Cottrell; Payton Solk; Emily A Torre; Danielle Blanch-Hartigan; Siobhan M Phillips Journal: Support Care Cancer Date: 2019-07-31 Impact factor: 3.603
Authors: David H Epstein; Matthew Tyburski; William J Kowalczyk; Albert J Burgess-Hull; Karran A Phillips; Brenda L Curtis; Kenzie L Preston Journal: NPJ Digit Med Date: 2020-03-04
Authors: Alan K Davis; Brooke J Arterberry; Erin E Bonar; Stephen T Chermack; Frederic C Blow; Rebecca M Cunningham; Maureen A Walton Journal: Drug Alcohol Depend Date: 2018-05-05 Impact factor: 4.492
Authors: Predrag Klasnja; Eric B Hekler; Elizabeth V Korinek; John Harlow; Sonali R Mishra Journal: Proc SIGCHI Conf Hum Factor Comput Syst Date: 2017-05